NCT00835575View on ClinicalTrials.gov

15 mg Mirtazapine Orally Disintegrating Tablets, Fasting

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

August 31, 2003

Study Completion Date

August 31, 2003

Conditions
Healthy
Interventions
DRUG

Mirtazapine 15 mg (Orally Disintegrating) Tablets

1 x 15 mg, single-dose fasting

DRUG

REMERON SolTab® 15 mg Orally Disintegrating Tablets

1 x 15 mg, single-dose fasting

Trial Locations (1)

58104

PRACS Institute, Ltd., Fargo

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00835575 - 15 mg Mirtazapine Orally Disintegrating Tablets, Fasting | Biotech Hunter | Biotech Hunter